Nextech Invest, Ltd.
Exempt adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | — | — |
| Apr 2025 to Mar 2026 | — | — |
| Apr 2024 to Mar 2025 | — | — |
| Jun 2023 to Mar 2024 | — | — |
| May 2023 | $0 | — |
| Sep 2022 to Apr 2023 | — | — |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.4%; sector active share 90.6% against the combined 13F book's sector weights.
Over time 6 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
15 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,099,516,941 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | −502,276 | 3,553,585 | $113,501,504 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | 4,663,176 | $127,631,127 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 7,601,087 | $1,423,531,573 | 67.80% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
NEW | 4,663,176 | $127,631,127 | 6.08% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 6,776,506 | $126,788,427 | 6.04% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Reduced | 3,553,585 | $113,501,504 | 5.41% | |
| ALMS |
Alumis Inc.
Healthcare
|
Held | 3,540,998 | $99,643,683 | 4.75% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 7,162,637 | $77,571,358 | 3.69% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 278,896 | $31,981,004 | 1.52% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Held | 1,113,946 | $29,118,548 | 1.39% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 761,153 | $18,419,902 | 0.88% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Held | 4,449,932 | $16,687,245 | 0.79% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 952,400 | $10,457,352 | 0.50% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Added | 1,122,713 | $9,329,745 | 0.44% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Held | 450,000 | $6,723,000 | 0.32% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 7,419,355 | $4,110,322 | 0.20% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 2,324,943 | $4,022,151 | 0.19% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.